Fieldpoint Private Securities’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1K Sell
5
-40
-89% -$5.79K ﹤0.01% 1365
2022
Q1
$7K Buy
45
+35
+350% +$5.77K ﹤0.01% 1190
2021
Q4
$2K Hold
10
﹤0.01% 1486
2021
Q3
$2K Sell
10
-80
-89% -$14.6K ﹤0.01% 1485
2021
Q2
$16K Buy
90
+80
+800% +$13.8K ﹤0.01% 879
2021
Q1
$2K Hold
10
﹤0.01% 1391
2020
Q4
$1K Buy
+10
New +$1.26K ﹤0.01% 1423

Other funds holding MEDP

Fieldpoint Private Securities's MEDP Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Medpace (MEDP) stake by 89% in Q2 2022, selling an estimated $5.79K and leaving 5 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1365.

Fieldpoint Private Securities first reported a position in MEDP in Q4 2020 and has held it in 7 quarters since. The position peaked at $16K in Q2 2021. 338 funds tracked by Wall St. Rank hold MEDP as of Q2 2022.

  • Fieldpoint Private Securities held 5 shares of Medpace worth $1K as of Q2 2022.
  • Fieldpoint Private Securities sold 40 Medpace shares in Q2 2022, an estimated $5.79K.
  • Medpace made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1365 holding.
  • Fieldpoint Private Securities first reported a position in Medpace in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's Medpace position peaked at $16K in Q2 2021.
  • 338 funds tracked by Wall St. Rank held Medpace as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.